Clinical Trial Update: Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence [Phase 3]

View source ↗

Summary

Phase 3 long-term follow-up study of Botulinum Toxin Type A for idiopathic overactive bladder with urinary incontinence completed; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Allergan | Conditions: Overactive Bladder, Urinary Incontinence | Phase 3 | Status: COMPLETED | Results posted: 2015-12-18